Culbert, Gabriel J.
Pillai, Veena
Bick, Joseph
Al-Darraji, Haider A.
Wickersham, Jeffrey A.
Wegman, Martin P.
Bazazi, Alexander R.
Ferro, Enrico
Copenhaver, Michael
Kamarulzaman, Adeeba
Altice, Frederick L.
Funding for this research was provided by:
National Institute on Drug Abuse (R01 DA025943, K24 DA017072, K01 DA038529, F30DA039716)
Universiti Malaya (E-000001-20001)
Fogarty International Center (R25 TW009338)
National Institute of Mental Health (F30MH105153)
Article History
Received: 26 February 2016
Accepted: 22 April 2016
First Online: 24 May 2016
Compliance with Ethical Standards
:
: Funding for this research was provided by the National Institute on Drug Abuse for research (R01 DA025943 to F.L.A.) and career development (K24 DA017072 to F.L.A., K01 DA038529 to J.A.W, F30 DA039716 to A.R.B). Additional funding was provided for research by the University of Malaya’s High Impact Research Grant (E-000,001-20,001 to A.K.) and for career development by NIAID Global Health Equity Scholars Program (R25 TW009338 to G.J.C.), National Institute of Mental Health (F30MH105153 to M.P.W.), Doris Duke Charitable Foundation through a grant supporting the Doris Duke International Clinical Research Fellows Program at Yale University School of Medicine to M.P.W., and Yale University (Yale College Fellowship for Research in Health Studies) to E.G.F.
: All authors report no conflicts of interest.